25
Preventing Stroke in Patients Undergoing Cardioversion

Preventing Stroke in Patients Undergoing Cardioversion

Embed Size (px)

DESCRIPTION

Preventing Stroke in Patients Undergoing Cardioversion. Anticoagulation in Patients With AF. Other Post-hoc Analyses of NOAC Therapy in Patients Undergoing Cardioversion. X-VeRT Baseline Demographics. X-VeRT Exclusion Criteria. X-VeRT Design. X-VeRT Design. X-VeRT Exclusion Criteria. - PowerPoint PPT Presentation

Citation preview

Preventing Stroke in Patients Undergoing Cardioversion

Anticoagulation in Patients With AF

Other Post-hoc Analyses of NOAC Therapy in Patients Undergoing

Cardioversion

X-VeRTBaseline Demographics

X-VeRT Exclusion Criteria

X-VeRT Design

X-VeRT Design

X-VeRT Exclusion Criteria

X-VeRT Design

X-VeRT Primary Efficacy

X-VeRTPrimary Efficacy Components

X-VeRT Primary Efficacy

X-VeRT Safety Outcomes

X-VeRT Summary of Results

X-VeRT Summary of Results

X-VeRT Study Limitations

Treatment of Very Early Onset AF

Conclusions

Abbreviations

Abbreviations (cont)

References

References (cont)

References (cont)